VitaNova Life Sciences annual operating cash flow
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
VitaNova Life Sciences Operating Cash Flow Growth & History (VNOV)
VitaNova Life Sciences's operating cash flow was $814,407 for fiscal 2026.
View full VitaNova Life Sciences company overviewVitaNova Life Sciences annual operating cash flow history
| Fiscal year | Period ended | Operating cash flow | Change | Growth |
|---|---|---|---|---|
| 2026 | 2026-04-30 | $814,407 | $621,633 | +322.47% |
| 2025 | 2025-04-30 | $192,774 | $568,654 | — |
| 2024 | 2024-04-30 | −$375,880 | −$357,505 | — |
| 2023 | 2023-04-30 | −$18,375 | −$22,436 | — |
| 2022 | 2022-04-30 | $4,061 | $46,347 | — |
| 2021 | 2021-04-30 | −$42,286 | $11,293 | — |
| 2020 | 2020-04-30 | −$53,579 | −$4,466 | — |
| 2019 | 2019-04-30 | −$49,113 | −$39,818 | — |
| 2018 | 2018-04-30 | −$9,295 | — | — |
| 2017 | 2017-01-25 | −$6,494 | — | — |
VitaNova Life Sciences quarterly operating cash flow
Q2.18
Q3.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
Q3.26
Q4.26
| Fiscal quarter | Period ended | Operating cash flow | Change | YoY change |
|---|---|---|---|---|
| Q4 2026 | 2026-04-30 | $428,313 | −$50,824 | −10.61% |
| Q3 2026 | 2026-01-31 | −$90,377 | −$299,255 | — |
| Q2 2026 | 2025-10-31 | $212,661 | $203,901 | +2327.64% |
| Q1 2026 | 2025-07-31 | $263,810 | $767,811 | — |
| Q4 2025 | 2025-04-30 | $479,137 | $670,322 | — |
| Q3 2025 | 2025-01-31 | $208,878 | $359,435 | — |
| Q2 2025 | 2024-10-31 | $8,760 | $16,751 | — |
| Q1 2025 | 2024-07-31 | −$504,001 | −$477,854 | — |
| Q4 2024 | 2024-04-30 | −$191,185 | −$188,900 | — |
| Q3 2024 | 2024-01-31 | −$150,557 | −$122,380 | — |
| Q2 2024 | 2023-10-31 | −$7,991 | −$13,297 | — |
| Q1 2024 | 2023-07-31 | −$26,147 | −$32,928 | — |
| Q4 2023 | 2023-04-30 | −$2,285 | $11,547 | — |
| Q3 2023 | 2023-01-31 | −$28,177 | −$33,419 | — |
| Q2 2023 | 2022-10-31 | $5,306 | −$14,287 | −72.92% |
| Q1 2023 | 2022-07-31 | $6,781 | $13,723 | — |
| Q4 2022 | 2022-04-30 | −$13,832 | −$13,832 | — |
| Q3 2022 | 2022-01-31 | $5,242 | $16,957 | — |
| Q2 2022 | 2021-10-31 | $19,593 | $50,164 | — |
| Q1 2022 | 2021-07-31 | −$6,942 | −$6,942 | — |
| Q4 2021 | 2021-04-30 | $0 | $14,797 | — |
| Q3 2021 | 2021-01-31 | −$11,715 | −$4,500 | — |
| Q2 2021 | 2020-10-31 | −$30,571 | −$18,888 | — |
| Q1 2021 | 2020-07-31 | $0 | $19,884 | — |
| Q4 2020 | 2020-04-30 | −$14,797 | −$1,151 | — |
| Q3 2020 | 2020-01-31 | −$7,215 | $29,481 | — |
| Q2 2020 | 2019-10-31 | −$11,683 | −$23,731 | — |
| Q1 2020 | 2019-07-31 | −$19,884 | −$9,065 | — |
| Q4 2019 | 2019-04-30 | −$13,646 | −$17,580 | — |
| Q3 2019 | 2019-01-31 | −$36,696 | −$41,116 | — |
| Q2 2019 | 2018-10-31 | $12,048 | $35,970 | — |
| Q1 2019 | 2018-07-31 | −$10,819 | −$17,092 | — |
| Q4 2018 | 2018-04-30 | $3,934 | — | — |
| Q3 2018 · Jan 31 | 2018-01-31 | $4,420 | — | — |
| Q3 2018 · Oct 31 | 2017-10-31 | −$23,922 | — | — |
| Q2 2018 | 2017-07-31 | $6,273 | — | — |
VitaNova Life Sciences operating cash flow trends
Over the last five fiscal years, VitaNova Life Sciences's operating cash flow increased from −$42,286 to $814,407, a change of $856,693. The latest reported quarter, Q4 2026, shows $428,313.
About the metric
What operating cash flow means
Operating cash flow is the cash generated or used by a company’s core operations. It incorporates working-capital movements and other operating cash items, and it is the starting point for calculating free cash flow.
Calculation and source
SEC-reported operating cash flow
TickerStat standardizes net cash provided by or used in operating activities reported in company SEC filings. It is historical filing data before capital expenditures, financing activities, and investing activities. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review VitaNova Life Sciences source filings ↗